What is the role of the rheumatologist in recommending and providing GLP-1 medications to their patients given the benefits across many disease domains including osteoarthritis?

This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeting. This question was inspired by the session "Novel Indications for Hypoglycemic Agents in Rheumatic Diseases: Sodium-Glucose Co-Transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists" by Dr. Louis Aronne, Dr. Brittany Weber and Dr. Isabelle Ayoub.

Answer from: at Academic Institution

Obesity has long been discussed in the literature as the most modifiable risk factor for knee osteoarthritis pain and progression, with a reduction in knee OA attributed to the decrease in mechanical load. But for the last decade, there has been much attention placed on the impact of metabolic facto...

Comments

at UCLA
We should have more rheumatologists who are traine...

at Western Washington Medical Group
I added obesity treatment to my rheumatology pract...

Please select the option that best describes you:

What is the role of the rheumatologist in recommending and providing GLP-1 medications to their patients given the benefits across many disease domains including osteoarthritis?

Related Questions